FGD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.074800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.614800E-01
Normal-vs-Stage2
3.956000E-01
Normal-vs-Stage3
9.613600E-01
Normal-vs-Stage4
1.028760E-01
Stage1-vs-Stage2
7.038000E-01
Stage1-vs-Stage3
2.201800E-01
Stage1-vs-Stage4
3.379800E-01
Stage2-vs-Stage3
3.000200E-01
Stage2-vs-Stage4
1.808810E-01
Stage3-vs-Stage4
8.321700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.196200E-01
Normal-vs-AfricanAmerican
4.741600E-01
Normal-vs-Asian
6.932000E-01
Caucasian-vs-AfricanAmerican
5.926800E-01
Caucasian-vs-Asian
4.828600E-01
AfricanAmerican-vs-Asian
4.611400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.546000E-01
Normal-vs-Female
3.517200E-01
Male-vs-Female
8.077200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.692400E-01
Normal-vs-Age(41-60Yrs)
2.210400E-01
Normal-vs-Age(61-80Yrs)
5.481000E-01
Normal-vs-Age(81-100Yrs)
5.696200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.014400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.758600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.246200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.699000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.575580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.139800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.675400E-01
Normal-vs-Daily Drinker
7.338200E-01
Normal-vs-Weekly Drinker
7.127200E-01
Normal-vs-Occasional Drinker
2.482200E-01
Normal-vs-Social Drinker
2.049000E-01
Non Drinker-vs-Daily Drinker
6.345600E-01
Non Drinker-vs-Weekly Drinker
9.633000E-01
Non Drinker-vs-Occasional Drinker
1.726640E-01
Non Drinker-vs-Social Drinker
3.161800E-01
Daily Drinker-vs-Weekly Drinker
8.043400E-01
Daily Drinker-vs-Occasional Drinker
1.497820E-01
Daily Drinker-vs-Social Drinker
2.518800E-01
Weekly Drinker-vs-Occasional Drinker
3.858600E-01
Weekly Drinker-vs-Social Drinker
5.445000E-01
Occasional Drinker-vs-Social Drinker
7.128200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.201820E-01
Normal-vs-Grade 2
1.174250E-02
Normal-vs-Grade 3
2.695800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.697200E-01
Grade 1-vs-Grade 3
3.261800E-02
Grade 1-vs-Grade 4
1.201820E-01
Grade 2-vs-Grade 3
8.644300E-02
Grade 2-vs-Grade 4
1.174250E-02
Grade 3-vs-Grade 4
2.695800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.486600E-01
Normal-vs-NonDiabetic
3.747200E-01
Diabetic-vs-NonDiabetic
9.586400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.620000E-01
Normal-vs-NoPancreatitis
4.626000E-01
Pancreatitis-vs-NoPancreatitis
9.513200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.529600E-01
Normal-vs-N1
3.788000E-01
N0-vs-N1
6.136400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.062800E-01
Normal-vs-TP53-NonMutant
3.923400E-01
TP53-Mutant-vs-TP53-NonMutant
1.692430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
